{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:23:52Z","timestamp":1789788232689,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T00:00:00Z","timestamp":1669766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jinf.2022.11.020","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T01:21:21Z","timestamp":1669857681000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders"],"prefix":"10.1016","volume":"86","author":[{"given":"Chunhui","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiming","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuetian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhou","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengkui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhou","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jinf.2022.11.020_bib0001","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"issue":"5","key":"10.1016\/j.jinf.2022.11.020_bib0002","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00277-019-03622-0","article-title":"Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO)","volume":"98","author":"Kochanek","year":"2019","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.jinf.2022.11.020_bib0003","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1017\/S0950268814001654","article-title":"Epidemiology and outcome of bacteraemia in neutropenic patients in a single institution from 1991 to 2012","volume":"143","author":"Ortega","year":"2015","journal-title":"Epidemiol Infect"},{"issue":"6","key":"10.1016\/j.jinf.2022.11.020_bib0004","first-page":"1068","article-title":"Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance","volume":"70","author":"Martinez-Nadal","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2022.11.020_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.hoc.2017.08.004","article-title":"Neutropenic fever","volume":"31","author":"White","year":"2017","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"10.1016\/j.jinf.2022.11.020_bib0006","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/14787210.2019.1573670","article-title":"Management of febrile neutropenia in the perspective of antimicrobial de-escalation and discontinuation","volume":"17","author":"Schmidt-Hieber","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"6","key":"10.1016\/j.jinf.2022.11.020_bib0007","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/QCO.0b013e32833ef7d1","article-title":"New molecular and surrogate biomarker-based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic patients","volume":"23","author":"Chen","year":"2010","journal-title":"Curr Opin Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2022.11.020_bib0008","doi-asserted-by":"crossref","first-page":"227","DOI":"10.21037\/atm.2020.01.30","article-title":"Diagnostic value and clinical application of next-generation sequencing for infections in immunosuppressed patients with corticosteroid therapy","volume":"8","author":"Wang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jinf.2022.11.020_bib0009","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu","year":"2019","journal-title":"Annu Rev Pathol"},{"issue":"25","key":"10.1016\/j.jinf.2022.11.020_bib0010","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa1401268","article-title":"Actionable diagnosis of neuroleptospirosis by next-generation sequencing","volume":"370","author":"Wilson","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jinf.2022.11.020_bib0011","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1111\/jcmm.14624","article-title":"Applications of sequencing technology in clinical microbial infection","volume":"23","author":"Yu","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.020_bib0012","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12890-019-0801-2","article-title":"Anantham D. Utility of bronchoalveolar lavage in the management of immunocompromised patients presenting with lung infiltrates","volume":"19","author":"Choo","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.020_bib0013","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13613-016-0189-6","volume":"6","author":"Schnell","year":"2016","journal-title":"Ann Intensive Care"},{"issue":"4","key":"10.1016\/j.jinf.2022.11.020_bib0014","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jamaoncol.2019.4120","article-title":"Evaluation of plasma microbial cell-free DNA sequencing to predict bloodstream infection in pediatric patients with relapsed or refractory cancer","volume":"6","author":"Goggin","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jinf.2022.11.020_bib0015","author":"Eichenberger","year":"2021","journal-title":"Clinic Infect Dis"},{"issue":"3","key":"10.1016\/j.jinf.2022.11.020_bib0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease","volume":"92","author":"Hong","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"5","key":"10.1016\/j.jinf.2022.11.020_bib0017","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/INF.0000000000003038","article-title":"Use of plasma metagenomic next-generation sequencing for pathogen identification in pediatric endocarditis","volume":"40","author":"To","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2022.11.020_bib0018","article-title":"Case report: comparison of plasma metagenomics to bacterial PCR in a case of prosthetic valve endocarditis","volume":"8","author":"Lieberman","year":"2020","journal-title":"Front Pediatr"},{"issue":"2","key":"10.1016\/j.jinf.2022.11.020_bib0019","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10096-016-2805-7","article-title":"Comprehensive detection and identification of bacterial DNA in the blood of patients with sepsis and healthy volunteers using next-generation sequencing method - the observation of DNAemia","volume":"36","author":"Gosiewski","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.020_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/cac2.12260","article-title":"Infection complications in febrile chimeric antigen receptor (CAR)-T recipients during the peri-CAR-T cell treatment period examined using metagenomic next-generation sequencing (mNGS)","author":"Nie","year":"2022","journal-title":"Cancer Commun"},{"issue":"11","key":"10.1016\/j.jinf.2022.11.020_bib0021","doi-asserted-by":"crossref","first-page":"ofab223","DOI":"10.1093\/ofid\/ofab223","article-title":"Next-generation sequencing to detect pathogens in pediatric febrile neutropenia: a single-center retrospective study of 112 cases","volume":"8","author":"Horiba","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.020_bib0022","article-title":"Plasma microbial cell-free DNA next generation sequencing in the diagnosis and management of febrile neutropenia","author":"Benamu","year":"2021","journal-title":"Clinic Infect Dis"},{"key":"10.1016\/j.jinf.2022.11.020_bib0023","first-page":"1","article-title":"CDC\/NHSN Surveillance definitioins for specific types of infections","volume":"17","year":"2019","journal-title":"Surveill Def"},{"issue":"4","key":"10.1016\/j.jinf.2022.11.020_bib0024","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clinic Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2022.11.020_bib0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41564-018-0349-6","article-title":"Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease","volume":"4","author":"Blauwkamp","year":"2019","journal-title":"Nat Microbiol"},{"issue":"12","key":"10.1016\/j.jinf.2022.11.020_bib0026","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.7150\/thno.45554","article-title":"Liquid biopsy for infectious diseases: a focus on microbial cell-free DNA sequencing","volume":"10","author":"Han","year":"2020","journal-title":"Theranostics"},{"issue":"8","key":"10.1016\/j.jinf.2022.11.020_bib0027","first-page":"643","article-title":"A single-center study on the distribution and antibiotic resistance of pathogens causing bloodstream infection in adult patients with hematological disease during the period 2014-2018","volume":"41","author":"Xu","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"4","key":"10.1016\/j.jinf.2022.11.020_bib0028","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s12185-021-03183-x","article-title":"Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study","volume":"114","author":"Okamoto","year":"2021","journal-title":"Int J Hematol"},{"issue":"6","key":"10.1016\/j.jinf.2022.11.020_bib0029","doi-asserted-by":"crossref","first-page":"e13186","DOI":"10.1111\/tid.13186","article-title":"Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: results from a multicentric surveillance cohort study","volume":"21","author":"Kern","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2022.11.020_bib0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/cid\/ciaa035","article-title":"Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study","volume":"72","author":"Hogan","year":"2021","journal-title":"Clinic Infect Dis"},{"issue":"24","key":"10.1016\/j.jinf.2022.11.020_bib0031","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1803396","article-title":"Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis","volume":"380","author":"Wilson","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jinf.2022.11.020_bib0032","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.3109\/10428194.2010.494260","article-title":"Diagnosis of Toxoplasma gondii infection after allogeneic stem cell transplant can be difficult and requires intensive scrutiny","volume":"51","author":"Cavattoni","year":"2010","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.jinf.2022.11.020_bib0033","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12185-013-1379-8","article-title":"Acute exacerbation of Toxoplasma gondii infection after hematopoietic stem cell transplantation: five case reports among 279 recipients","volume":"98","author":"Sumi","year":"2013","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.jinf.2022.11.020_bib0034","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jmii.2018.01.002","article-title":"Clinical characteristics and treatment outcomes of pulmonary invasive fungal infection among adult patients with hematological malignancy in a medical centre in Taiwan, 2008-2013","volume":"53","author":"Chen","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"issue":"5","key":"10.1016\/j.jinf.2022.11.020_bib0035","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.chest.2019.06.032","article-title":"Advances in the diagnosis and management of invasive fungal disease","volume":"156","author":"Formanek","year":"2019","journal-title":"Chest"},{"issue":"6","key":"10.1016\/j.jinf.2022.11.020_bib0036","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clinic Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jinf.2022.11.020_bib0037","first-page":"e1","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24","author":"Ullmann","year":"2018","journal-title":"Clinic Microbiol Infect"},{"issue":"12","key":"10.1016\/j.jinf.2022.11.020_bib0038","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S1473-3099(19)30312-3","article-title":"Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium","volume":"19","author":"Cornely","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5\u20136","key":"10.1016\/j.jinf.2022.11.020_bib0039","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000497319","article-title":"Evaluation of next-generation sequencing for the diagnosis of infections of the central nervous system caused by the neurotropic herpes viruses: a pilot study","volume":"80","author":"Xing","year":"2018","journal-title":"Eur Neurol"},{"issue":"suppl_2","key":"10.1016\/j.jinf.2022.11.020_bib0040","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/cid\/ciy693","article-title":"Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice","volume":"67","author":"Miao","year":"2018","journal-title":"Clinic Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.jinf.2023.01.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000}}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445322006818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:37:17Z","timestamp":1697107037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445322006818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S0163445322006818"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.020","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jinf.2023.01.011","asserted-by":"object"}]},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of plasma cell-free DNA next-generation sequencing for diagnosis of infectious diseases in patients with hematological disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2022.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association.","name":"copyright","label":"Copyright"}]}}